These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1995897

  • 1. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
    Randad RS, Mahran MA, Mehanna AS, Abraham DJ.
    J Med Chem; 1991 Feb; 34(2):752-7. PubMed ID: 1995897
    [Abstract] [Full Text] [Related]

  • 2. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.
    Abraham DJ, Wireko FC, Randad RS, Poyart C, Kister J, Bohn B, Liard JF, Kunert MP.
    Biochemistry; 1992 Sep 29; 31(38):9141-9. PubMed ID: 1390701
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and investigation of effects of 2-[4- [[(arylamino)carbonyl]amino]phenoxy]-2-methylpropionic acids on the affinity of hemoglobin for oxygen: structure-activity relationships.
    Lalezari I, Lalezari P.
    J Med Chem; 1989 Oct 29; 32(10):2352-7. PubMed ID: 2795607
    [Abstract] [Full Text] [Related]

  • 4. Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.
    Uchida K, Reilly MP, Abraham DJ, Asakura T.
    Jpn J Physiol; 1998 Dec 29; 48(6):439-44. PubMed ID: 10021497
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
    Omar AM, Mahran MA, Ghatge MS, Bamane FH, Ahmed MH, El-Araby ME, Abdulmalik O, Safo MK.
    Molecules; 2016 Aug 13; 21(8):. PubMed ID: 27529207
    [Abstract] [Full Text] [Related]

  • 9. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
    Teicher BA, Wong JS, Takeuchi H, Gravelin LM, Ara G, Buxton D.
    Cancer Chemother Pharmacol; 1998 Aug 13; 42(1):24-30. PubMed ID: 9619754
    [Abstract] [Full Text] [Related]

  • 10. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat.
    Grocott HP, Bart RD, Sheng H, Miura Y, Steffen R, Pearlstein RD, Warner DS.
    Stroke; 1998 Aug 13; 29(8):1650-5. PubMed ID: 9707208
    [Abstract] [Full Text] [Related]

  • 11. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
    Weiss RG, Mejia MA, Kass DA, DiPaula AF, Becker LC, Gerstenblith G, Chacko VP.
    J Clin Invest; 1999 Mar 13; 103(5):739-46. PubMed ID: 10074492
    [Abstract] [Full Text] [Related]

  • 12. Allosteric modification of oxygen delivery by hemoglobin.
    Wahr JA, Gerber M, Venitz J, Baliga N.
    Anesth Analg; 2001 Mar 13; 92(3):615-20. PubMed ID: 11226087
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pyridyl derivatives of benzaldehyde as potential antisickling agents.
    Nnamani IN, Joshi GS, Danso-Danquah R, Abdulmalik O, Asakura T, Abraham DJ, Safo MK.
    Chem Biodivers; 2008 Sep 13; 5(9):1762-9. PubMed ID: 18816529
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
    Abraham DJ, Kennedy PE, Mehanna AS, Patwa DC, Williams FL.
    J Med Chem; 1984 Aug 13; 27(8):967-78. PubMed ID: 6747995
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites.
    Safo MK, Boyiri T, Burnett JC, Danso-Danquah R, Moure CM, Joshi GS, Abraham DJ.
    Acta Crystallogr D Biol Crystallogr; 2002 Apr 13; 58(Pt 4):634-44. PubMed ID: 11914488
    [Abstract] [Full Text] [Related]

  • 19. How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium.
    Abraham DJ, Safo MK, Boyiri T, Danso-Danquah RE, Kister J, Poyart C.
    Biochemistry; 1995 Nov 21; 34(46):15006-20. PubMed ID: 7578114
    [Abstract] [Full Text] [Related]

  • 20. Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.
    Mahran MA.
    Boll Chim Farm; 2000 Nov 21; 139(2):73-80. PubMed ID: 10920532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.